Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss trials presented in American Society of Hematology (ASH) 2023 meeting. They provide some data on luspatercept, imetelstat, roxodustat and Ker-050.

New trials to address the anemia of lower-risk MDS [MDS Professional Report]

This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research.<br />The explosion of information on MDS forces us to seek novel, alternative ways to distribute it. Podcasts gives us an easy and popular way to communicate this information in a short time.

Medicine

Health & Fitness

This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research.The explosion of information on MDS forces us to seek novel, alternative ways to distribute it. Podcasts gives us an easy and popular way to communicate this information in a short time.

This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research.<br>The explosion of information on MDS forces us to seek novel, alternative ways to distribute it. Podcasts gives us an easy and popular way to communicate this information in a short time.

Share New trials to address the anemia of lower-risk MDS [MDS Professional Report]

Sign up to save your podcasts

New trials to address the anemia of lower-risk MDS [MDS Professional Report]

New trials to address the anemia of lower-risk MDS [MDS Professional Report]

More shows like MDS Professional Report

The Mel Robbins Podcast